KALV icon

KalVista Pharmaceuticals
KALV

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$28
107% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citizens
Citizens
Jonathan Wolleben
67% 1-yr KALV win rate
11 Nov ‘25 21 days ago
Needham
Needham
Serge Belanger
60% 1-yr KALV win rate
12 Sep ‘25 2 months ago